Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
First Trust NYSE Arca Biotechnology ETF Units (FBT : TSX)
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade A
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade E
Click for more information on Fundata’s ESG Grade.
|
Close (10-06-2026) |
$47.31 |
|---|---|
| Change |
-$1.24
(-2.55%)
|
| Open | $47.53 |
|---|---|
| Day Range | $47.48 - $47.53 |
| Volume | 515 |
As at August 31, 2026
As at August 31, 2026
As at August 31, 2026
Loading......
Loading......
Legend
Compare Options
Fund Returns
Inception Return (October 29, 2014): 9.52%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 7.76% | 20.51% | 29.95% | 30.47% | 56.53% | 27.07% | 21.07% | 19.88% | 10.99% | 14.00% | 12.90% | 9.14% | 9.75% | 9.52% |
| Benchmark | 3.05% | 11.29% | 5.27% | 9.13% | 20.35% | 5.23% | 9.72% | 10.36% | 5.71% | 7.78% | 9.64% | 8.50% | 9.86% | 9.55% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 2 / 55 | 2 / 55 | 1 / 54 | 2 / 53 | 2 / 53 | 2 / 52 | 2 / 50 | 1 / 43 | 1 / 42 | 1 / 40 | 1 / 37 | 4 / 36 | 3 / 31 | 5 / 29 |
| Quartile Ranking | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Monthly Return
| Return % | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 5.63% | 8.47% | 10.68% | -5.39% | 2.27% | -1.83% | -1.88% | -0.40% | 10.34% | 14.46% | -2.30% | 7.76% |
| Benchmark | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% | 3.08% | 7.68% | 0.29% | 3.05% |
Best Monthly Return Since Inception
14.46% (June 2026)
Worst Monthly Return Since Inception
-14.35% (March 2020)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 24.66% | 15.26% | -16.21% | 14.98% | 19.26% | -2.35% | 1.71% | 0.18% | 14.56% | 18.45% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 1 | 1 | 4 | 3 | 1 | 4 | 1 | 3 | 1 | 1 |
| Category Rank | 1/ 29 | 7/ 29 | 34/ 34 | 21/ 36 | 9/ 37 | 40/ 40 | 7/ 42 | 27/ 43 | 1/ 50 | 2/ 52 |
Best Calendar Return (Last 10 years)
24.66% (2016)
Worst Calendar Return (Last 10 years)
-16.21% (2018)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 82.68 |
| International Equity | 17.19 |
| Cash and Equivalents | 0.16 |
| Other | -0.03 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 99.87 |
| Cash and Cash Equivalent | 0.16 |
| Other | -0.03 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 82.81 |
| Europe | 13.46 |
| Asia | 3.74 |
| Other | -0.01 |
Top Holdings
| Name | Percent |
|---|---|
| First Trust NYSE Arca Biotechnology Idx ETF (FBT) | 99.96 |
| US DOLLAR | 0.03 |
| Cash and Cash Equivalents | 0.01 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
First Trust NYSE Arca Biotechnology ETF Units
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 19.48% | 17.24% | 17.81% |
|---|---|---|---|
| Beta | 1.23% | 1.06% | 0.97% |
| Alpha | 0.09% | 0.05% | 0.01% |
| Rsquared | 0.57% | 0.54% | 0.40% |
| Sharpe | 0.91% | 0.52% | 0.49% |
| Sortino | 1.85% | 0.93% | 0.69% |
| Treynor | 0.14% | 0.08% | 0.09% |
| Tax Efficiency | 100.00% | 95.37% | 92.92% |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 22.15% | 19.48% | 17.24% | 17.81% |
| Beta | 1.29% | 1.23% | 1.06% | 0.97% |
| Alpha | 0.23% | 0.09% | 0.05% | 0.01% |
| Rsquared | 0.66% | 0.57% | 0.54% | 0.40% |
| Sharpe | 2.06% | 0.91% | 0.52% | 0.49% |
| Sortino | 6.50% | 1.85% | 0.93% | 0.69% |
| Treynor | 0.35% | 0.14% | 0.08% | 0.09% |
| Tax Efficiency | 100.00% | 100.00% | 95.37% | 92.92% |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | October 29, 2014 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $7 |
| 52 Week High | $48.81 |
| 52 Week Low | $32.23 |
| Annual Dividend | - |
| Annual Yield | - |
| Index | StrataQuant® Materials Index |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
ETF Characteristics
| Exposure | 1x performance |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
Investment Objectives
The Fund will seek to replicate, to the extent possible, the performance of an index of U.S. companies in the biotechnology industry, initially the NYSE Arca Biotechnology Index. The First Trust NYSE® Arca® Biotechnology Index is a rules-based equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies. Biotechnology companies are designated as those classified within the Biotechnology sub-industry group of the ICE Uniform Sector
Investment Strategy
According to the Index Provider, the First Trust NYSE® Arca® Biotechnology Index (the “Biotechnology Index”) is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Portfolio Management
| Portfolio Manager |
First Trust Advisors LP |
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
FT Portfolios Canada Co. |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
Fees
| MER | 0.71% |
|---|---|
| Management Fee | 0.15% |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
